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A B S T R A C T
Purpose: Mutations in the PRRT2 gene have been recently described as a cause of paroxysmal kinesigenic
dyskinesia, infantile convulsions with choreoathetosis syndrome and, less often, infantile convulsions.
We have analysed the frequency of PRRT2 mutations in families with benign familial infantile convulsions
without paroxysmal kinesigenic dyskinesia.
Methods and results: Direct sequencing of the coding region identiﬁed the PRRT2 mutation c.649dupC in
5/5 families with infantile convulsions. The mutation was present in 23 family members, of which 18
were clinically affected and 2 were obligate carriers. The affected carriers of this mutation presented with
different types of epileptic seizures during early childhood but did not develop additional neurological
symptoms later in life.
Conclusion: Our data demonstrate that the PRRT2 mutation c.649dupC is a frequent cause of benign
familial infantile convulsions.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Epilepsy is one of the most frequent neurological disorders with
a high prevalence in most populations. It is therefore not unusual
to observe families in which more than one member is affected.
However, most of these ‘‘familial’’ cases are multifactorial in origin
and only a minority of them are caused by single gene mutations.
Several examples of such rare genetic epilepsies for which
causative genes were identiﬁed have been published during the
last two decades, the most recent one being infantile convulsions
with choreoathetosis syndrome (ICCA, OMIM 602066).1–6 Typical-
ly patients with this rare syndrome are temporarily afﬂicted with
benign seizures that mostly occur between age 6 months and two
years. The seizures are tonic, tonic–clonic or atonic and can be
accompanied by gazing, unresponsiveness, cyanosis or head
deviation. During childhood or young adulthood the patients
develop paroxysmal dyskinesia that is characterized by short
attacks of dystonic posturing and choreatiform or athetotic
movements lasting for up to 5 min.* Corresponding author at: Institute of Human Genetics, University Hospital,
University of Munich, Goethestr. 29, 80336 Munich, Germany.
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E-mail addresses: Ortrud.Steinlein@med.uni-muenchen.de (O.K. Steinlein),
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1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.07.006Monogenic forms of infantile seizures without choreoathetosis
exist, known as separate genetic entities named benign familial
infantile convulsions (BFIC; OMIM 605751) or Fukuyama–Wata-
nabe–Vigevano syndrome.7 Both ICCA and BFIC have been
previously linked to the same region on chromosome 16.8,9
Recently, several groups described mutations in PRRT2 (proline-
rich transmembrane protein 2), a gene located in the chromosome
16 candidate region.1,10 The PRRT2 mutations were mainly found in
patients with either typical ICCA or isolated paroxysmal kinesi-
genic dyskinesia without preceding epilepsy. Furthermore, some
PRRT2 mutations were described in patients with infantile
convulsions without choreoathetosis, suggesting that ICCA and
BFIC are allelic.6 This hypothesis is supported by the families
presented here.
2. Methods
Blood samples were taken from the index patients and their
relatives from ﬁve BFIC families. All families were of German
descent. The patients provided informed consent for molecular
testing and the study was approved by the local ethics committee.
The families (with the exception of family D124 which was
recruited in 2012) were collected between 1995 and 2002, at
which point information about seizure onset and seizure type as
well as about psychomotor development were collected.
They were clinically re-evaluated in 2012, and information
was gathered about seizure remission, neurological status andvier Ltd. All rights reserved.
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that treated the patients during recruitment and who saw them
again for clinical evaluation in 2012. The complete coding
sequence of the PRRT2 gene was ampliﬁed by PCR and directly
sequenced using the Sanger method.
3. Results
The clinical details of the ﬁve BFIC families included in this
study are summarized in supplementary Table 1. The index
patients of these families (except D124) had been previously tested
negative for mutation in the KCNQ2 and KCNQ3 genes by direct
sequencing of the coding regions. The previously described
truncating PRRT2 mutation c.649dupC was found in all BFIC
patients for whom DNA was available but not in their unrelated
spouses. Within the ﬁve BFIC families ﬁve unaffected carriers
(either obligate (D12-II3, D75-II3) or proven to carry the mutation
(D75-III2, D96-IV1+3) were identiﬁed, indicating a reduced
penetrance for PRRT2-c.649dupC in our sample. The affected
carriers of this mutation presented with a wide spectrum of
epileptic seizures during their ﬁrst two years of life. These included
complex focal seizures, secondary generalized tonic clonic
seizures, as well as absence seizures. Clinical re-evaluation of all
families (except the recently recruited Family D124) 10–17 years
after the initial evaluation showed that none of the index patients
or affected family members developed choreoathetosis or other
neurological symptoms (except for migraine in D96-IV4 and in her
unaffected cousin (D96-IV1) who is a carrier of mutation
c.649dupC). In all patients seizures remitted either spontaneously
or after antiepileptic drug treatment was initiated, and no
recurrence occurred after treatment was discontinued. Psychomo-
tor development was normal in all patients.
4. Discussion
The human PRRT2 transcripts are primarily found in brain,
especially in basal ganglia and cortex (Ensembl). In mice they are
predominantly expressed in brain and spinal cord during
embryonic development and the postnatal stage.3 Three different
PRRT2 isoforms are encoded by transcripts that are alternatively
spliced in their 30 ends. The known mutations (Table 1) are located
in the part of the PRRT2 protein that all splice variants have in
common, thus the isoforms are unlikely to affect the clinical
outcome. The physiological functions of the different PRRT2
isoforms are largely unknown. Structural analysis predicts the
existence of transmembrane domains, thus PRRT2 is likely toTable 1
Summary of published PRRT2 mutations and associated clinical phenotypes.
Phenotype Mutation Number
of patients
Paroxysmal kinesigenic
dyskinesia
c.649dupC1,2,6,10 96
c.487C>T10 5
c.796C>T10 2
c.514_517delTCTG2 2
c.972delA2 1
c.748C>T6 1
ICCA c.649dupC6 16
c.573dupT1 1
BFIC c.649dupC6,10 13 +18
c.487C>T10 2
c.748C>T6 1
Only those publications are included that provide clinical details for individual
family members. +, present study.be membrane bound. Yeast two-hybrid studies suggested an
nteraction with SNAP25 (synaptosomal-associated protein
25 kDa), a protein known to be involved in neurotransmitter
release from synaptic vesicles. Thus it is possible that PRRT2 is
indirectly involved in synaptic transmission, a physiological
process crucial for most brain functions. An association between
a membrane spanning protein and a clinical phenotype that
combines both epilepsy and movement disorder has been
previously described in the glucose transporter-1 deﬁciency
syndrome, caused by mutations in the SLC2A1 gene.11
Heterozygous truncating mutations such as PRRT2 c.649dupC
are likely to signiﬁcantly decrease the amount of available
protein. They can even cause a dominant negative effect in
which the truncated protein interferes with the normal PRRT2
protein transcribed from second allele. Both mechanisms can be
predicted to result in a considerable loss-of-function effect. The
mutation c.649dupC is the most commonly found alteration in
both paroxysmal kinesigenic dyskinesia and ICCA patients (108/
120 published patients, see Table 1). The data reported here
conﬁrm that this speciﬁc PRRT2 mutation is also so far the most
frequent cause of BIFC. It is not known why one and the same
mutation can cause both epilepsy and movement disorder in
some patients, but only epilepsy in others. In most of the
previous publications both clinical phenotypes coexisted in
families with this mutation.1,10 Our ﬁve families show that
c.649dupC can be associated with a uniform intrafamilial clinical
outcome. The 21 patients reported here (18 of them proven
mutation carriers, 3 clinically affected but not genetically tested;
Fig. 1) all had a benign type of early childhood epilepsy but none
of them developed paroxysmal kinesigenic dyskinesia or related
neurological symptoms. One possible explanation for this
uniform clinical expression would be ascertainment bias,
meaning that we were collecting familial epilepsies and patients
with the more severe phenotype of paroxysmal kinesigenic
dyskinesia might simply have not been reported to us. This
explanation is less likely because most of our index patientsI 1 2
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Fig. 1. (A and B) BFIC pedigrees. Black stars, heterozygous for mutation c.649dupC;
white stars, homozygous for wild type allete; dark symbols, clinically affected by BFIC.
O.K. Steinlein et al. / Seizure 21 (2012) 740–742742were recruited by neuropaediatricians that encountered these
patients years before the movement disorder in ICCA usually
starts. Another explanation would be that the mutation
c.649dupC by itself is not sufﬁcient to cause the later onset
neurological phenotype of paroxysmal kinesigenic dyskinesia
but that so far unknown additional genetic or environmental
factors are necessary for such an outcome. The latter hypothesis
is supported by the fact that the previously reported families
with PRRT2-c.649dupC originated from China, Japan and
Australia while our families were of German descent. Such
differences in origin are likely to be associated with differences
in both genetic background and environment. It will be
interesting to identify additional c.649dupC patients from
adjacent European countries to ﬁnd out if they share the
uniformly benign clinical outcome observed in our German
family sample, or if the epilepsy-only phenotype described here
is an artefact caused by the small sample size.
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